Pea F - Search Results

1

Ceftolozane/tazobactam: place in therapy.

Giacobbe DR, Bassetti M, De Rosa FG, Del Bono V, Grossi PA, Menichetti F, Pea F, Rossolini GM, Tumbarello M, Viale P, Viscoli C; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva). Giacobbe DR, et al. Among authors: pea f. Expert Rev Anti Infect Ther. 2018 Apr;16(4):307-320. doi: 10.1080/14787210.2018.1447381. Epub 2018 Mar 9. Expert Rev Anti Infect Ther. 2018. PMID: 29493397 Free article. Review.

2

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.

Pea F, Brollo L, Viale P, Pavan F, Furlanut M. Pea F, et al. J Antimicrob Chemother. 2003 Apr;51(4):971-5. doi: 10.1093/jac/dkg147. Epub 2003 Feb 25. J Antimicrob Chemother. 2003. PMID: 12654757

3

Antimicrobial agents in elective surgery: prophylaxis or "early therapy"?

Pea F, Viale P, Furlanut MI. Pea F, et al. J Chemother. 2003 Feb;15(1):3-11. doi: 10.1179/joc.2003.15.Supplement-2.3. J Chemother. 2003. PMID: 12678408 Review.

4

[What role for fluoroquinolones in intensive therapy?].

Viale P, Pea F. Viale P, et al. Among authors: pea f. J Chemother. 2003 Aug;15 Suppl 1:5-10. J Chemother. 2003. PMID: 14535066 Review. Italian. No abstract available.

5

What is the role of fluoroquinolones in intensive care?

Viale P, Pea F. Viale P, et al. Among authors: pea f. J Chemother. 2003 Nov;15 Suppl 3:5-10. doi: 10.1080/1120009x.2003.11782356. J Chemother. 2003. PMID: 14708959 Review.

6

Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.

Pea F, Viale P, Candoni A, Pavan F, Pagani L, Damiani D, Casini M, Furlanut M. Pea F, et al. Clin Pharmacokinet. 2004;43(6):405-15. doi: 10.2165/00003088-200443060-00004. Clin Pharmacokinet. 2004. PMID: 15086277 Clinical Trial.

7

Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.

Pea F, Viale P, Lugano M, Pavan F, Scudeller L, Della Rocca G, Furlanut M. Pea F, et al. Am J Kidney Dis. 2004 Dec;44(6):1097-102. doi: 10.1053/j.ajkd.2004.08.032. Am J Kidney Dis. 2004. PMID: 15558532

8

Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.

Pea F, Viale P, Damiani D, Pavan F, Cristini F, Fanin R, Furlanut M. Pea F, et al. Antimicrob Agents Chemother. 2005 Aug;49(8):3550-3. doi: 10.1128/AAC.49.8.3550-3553.2005. Antimicrob Agents Chemother. 2005. PMID: 16048982 Free PMC article.

9

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Pea F, Viale P, Furlanut M. Pea F, et al. Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.

10

Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery.

Pea F, Furlanut M, Stellini R, Bonardelli S, Signorini L, Pavan F, Matheis A, Portolani N, Lorenzotti S, Giulini SM, Viale P, Carosi G. Pea F, et al. Int J Antimicrob Agents. 2006 Jan;27(1):15-9. doi: 10.1016/j.ijantimicag.2005.09.009. Epub 2005 Dec 15. Int J Antimicrob Agents. 2006. PMID: 16343858 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page